BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26349668)

  • 21. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment.
    Li F; Li S; Wei L; Liang X; Zhang H; Liu J
    Biomarkers; 2013 Nov; 18(7):632-7. PubMed ID: 24066812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic Change in Serum Alpha-fetoprotein Level Predicts Treatment Response and Prognosis of Alpha-fetoprotein-producing Gastric Cancer.
    Wang R; Li J; Xu D; Li R; Gong P
    Medicine (Baltimore); 2020 Nov; 99(47):e23326. PubMed ID: 33217870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [AFP-producing gastric cancer and hepatoid gastric cancer].
    Wang YK; Zhang XT
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):801-807. PubMed ID: 29151285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma.
    Yang SL; Liu LP; Yang S; Liu L; Ren JW; Fang X; Chen GG; Lai PB
    Br J Surg; 2016 May; 103(6):716-724. PubMed ID: 26996727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An analysis of clinical characteristics and prognosis for patients with serum alpha-fetoprotein-positive gastric cancer.
    Zuo CT; Ju Q
    Minerva Med; 2015 Aug; 106(4):185-91. PubMed ID: 26418320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum carcinoembryonic antigen as a prognostic factor in resectable gastric cancer.
    Tachibana M; Takemoto Y; Nakashima Y; Kinugasa S; Kotoh T; Dhar DK; Kohno H; Nagasue N
    J Am Coll Surg; 1998 Jul; 187(1):64-8. PubMed ID: 9660027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of surgical resection for gastric cancer liver metastases: a retrospective analysis.
    Kawahara K; Makino H; Kametaka H; Hoshino I; Fukada T; Seike K; Kawasaki Y; Otsuka M
    World J Surg Oncol; 2020 Feb; 18(1):41. PubMed ID: 32093729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
    Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
    World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
    Blank S; Wang Q; Fiel MI; Luan W; Kim KW; Kadri H; Mandeli J; Hiotis SP
    Ann Surg Oncol; 2014 Mar; 21(3):986-94. PubMed ID: 24232510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic nutritional index as a predictor of survival in resectable gastric cancer patients with normal preoperative serum carcinoembryonic antigen levels: a propensity score matching analysis.
    Hirahara N; Tajima Y; Fujii Y; Kaji S; Yamamoto T; Hyakudomi R; Taniura T; Kawabata Y
    BMC Cancer; 2018 Mar; 18(1):285. PubMed ID: 29534689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multivariate prognostic study on large gastric cancer.
    Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
    J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer.
    Yasuda H; Toiyama Y; Ohi M; Mohri Y; Miki C; Kusunoki M
    J Surg Oncol; 2011 Jun; 103(7):695-9. PubMed ID: 21308684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients.
    Adachi Y; Tsuchihashi J; Shiraishi N; Yasuda K; Etoh T; Kitano S
    Oncology; 2003; 65(2):95-101. PubMed ID: 12931013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-fetoprotein (AFP) elevation gastric adenocarcinoma and importance of AFP change in tumor response evaluation.
    Tatli AM; Urakci Z; Kalender ME; Arslan H; Tastekin D; Kaplan MA
    Asian Pac J Cancer Prev; 2015; 16(5):2003-7. PubMed ID: 25773802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of histological findings and serum AFP levels in the prognosis of AFP-producing gastric cancers.
    Uefuji K; Ichikura T; Tamakuma S
    Jpn J Clin Oncol; 1994 Jun; 24(3):135-40. PubMed ID: 7516444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological and prognostic features of hepatoid adenocarcinoma of the stomach.
    Zhang JF; Shi SS; Shao YF; Zhang HZ
    Chin Med J (Engl); 2011 May; 124(10):1470-6. PubMed ID: 21740800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers.
    Chang YC; Nagasue N; Abe S; Taniura H; Kumar DD; Nakamura T
    Am J Gastroenterol; 1992 Mar; 87(3):321-5. PubMed ID: 1371637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation.
    Zhang Q; Shang L; Zang Y; Chen X; Zhang L; Wang Y; Wang L; Liu Y; Mao S; Shen Z
    Eur J Gastroenterol Hepatol; 2014 May; 26(5):544-52. PubMed ID: 24614696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
    Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
    J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.